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Abstract
Background: Collision tumors of the colon are rare. We report the first case, to our knowledge
in the English literature, of a collision tumor composed of a colonic adenocarcinoma arising in a
sigmoid diverticulum coexisting with a recurrent ovarian granulosa cell tumor.
Case presentation: A 64-year old woman presented with small bowel obstruction and a large,
heterogenous, solid/cystic serosal based pelvic mass consistent with a gastrointestinal stromal
tumor on imaging. Her significant past history 16-years ago included a bilateral salpingo-
oophrectomy with hysterectomy. Surgical removal of the mass and pathological examination
revealed the presence of a colonic adenocarcinoma arising in a large sigmoid diverticulum
coexistent with a second neoplastic tumor phenotype; confirmed to be a delayed recurrent ovarian
granulosa cell tumor. Though coexistent, the two tumor phenotypes respected their boundaries
with no diffuse intermingling or transition between them. She developed lung metastases from the
recurrent ovarian tumor within 6 months and died within a year of follow-up.
Conclusion: Collision tumors of the colon are rare. This is the first case reported of a collision
tumor composed of adenocarcinoma colon and recurrent granulosa cell tumor representing an
example of two independent tumors in a unique one-on-another collision. Clinical awareness and
recognition of such tumors are important as they will dictate appropriate treatment strategies
dependent on the individual biological aggressiveness of each of the tumor components. Our
report highlights the need for histopathologists, surgeons, and oncologists to be aware of the rare
possibility of collisions tumors. As seen in our case, the delayed recurrence of granulosa cell tumor
of the ovary sixteen years after the initial presentation was the key determining factor in tumor
recurrence, tumor progression, and tumor metastasis within three months, which ultimately lead
to accelerated death within a year of clinical presentation. Thus accurate identification and
recognition of the second neoplasm is important as prognosis and survival may be determined by
this component as seen in our index case.
Background
A composite tumor is described as a lesion that has differ-
ent components of a tumor intermingling in a way
wherein the two components are difficult to distinguish
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from each other in many areas [1]. A true "collision"
tumor on the other hand represents a coexistence of two
adjacent but histologically different malignant neo-
plasm's occurring in the same organ without histological
admixture or an intermediate cell population zone [1].
Such tumors consist of components with different his-
togenesis and different tumorigenetic pathways represent-
ing a mosaic of two concurrent but independent tumors
that have "collided" with each other. Thus, "collision"
tumors are synchronous morphologically different neigh-
boring neoplasm's that have expanded into each others
territory and are occurring side by side in the same organ.
Without special or unique clinical features, such tumors
are difficult to diagnose preoperatively and pathological
identification of the dual components is often the only
way to make a correct diagnosis.
The occurrence of collision tumors in the human body is
rare and even rarer in the colon. Reported cases include
adenoma of the colon and carcinoid [2], adenocarcinoma
of the colon and carcinoid [3], adenocarcinoma of the
colon and transitional cell carcinoma of the bladder [4],
Non-Hodgkin lymphoma and adenocarcinoma of the
colon [5-9], and adenocarcinoma of the colon and perito-
neal metastasis of a hepatoid variant of yolk sac tumor
[10]. Our case represents an example of a true collision
tumor composed of two independent tumors occurring in
a unique one-on-another pattern: i) sixteen year delayed
recurrence of a granulosa cell tumor of the ovary coexist-
ing with ii) a primary colonic adenocarcinoma. To the
best of our knowledge, this is the first reported case in the
English literature.
Case presentation
A 64 year old woman presented with small bowel obstruc-
tion and a pelvic mass. Her significant past history
included a bilateral salpingo-oophrectomy with hysterec-
tomy sixteen years ago which on retrospective investiga-
tion and tracking of medical records was attributed as
surgery for an ovarian granulosa cell tumor. Imaging stud-
ies with an abdominal ultrasound showed the presence of
a mass which was followed by a CT scan which showed
the presence of a large, heterogenous, solid/cystic serosal
based pelvic mass that was felt to be an extracolonic gas-
trointestinal stromal tumor (Figure 1). Positron emission
tomography or colonoscopy was not undertaken. Recur-
rent ovarian carcinoma or a complicated pelvic abscess
was also offered as a radiological differential diagnosis.
She underwent an explorative laparotomy with en-bloc
removal of the pelvic mass.
Pathologic findings
On gross examination, the segment of the colon with
overlying fatty tissue and attached firm mass weighed 467
g. The colonic segment measured 25 cm in length and
contained a neoplastic lesion measuring 12.0 × 12.0 ×
12.0 cm in maximum dimensions. The bowel mucosa was
tan colored, unremarkable and showed normal folding
pattern overlying the predominantly serosal based neo-
plastic mass being pale tan in color to red-brown in color
with several necrotic areas. Two components of tumor
were not identified on gross though there were some
streaks of 'orange' colored tissue in one adjacent region of
the specimen (Figure 2).
Gross photograph of the specimen composed of colonic seg- ment containing a predominantly serosal based neoplastic  lesion measuring 12 Figure 2
Gross photograph of the specimen composed of colonic seg-
ment containing a predominantly serosal based neoplastic 
lesion measuring 12.0 × 12.0 × 12.0 cm in maximum dimen-
sions (asterisks).
CT scan showing the presence of a large, heterogenous,  solid/cystic serosal based pelvic mass (arrows) Figure 1
CT scan showing the presence of a large, heterogenous, 
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Microscopically, the granulosa cell tumor was composed
of fairly large monotonous cells with eosinophilic cyto-
plasm and nuclei being predominantly oval. Many archi-
tectural patterns including diffuse, micro-follicular and
cords of neoplastic cells (Figure 3A, B, and 3C) were seen.
The recurrence was predominantly seen along the perito-
neal surface of the bowel and along the lateral pelvic wall.
Isolated adenocarcinoma glandular cells were also identi-
fied fortuitously in some regions. Further sections showed
the focus of the predominant growth of the typical dirty
necrosis with glandular formation of a colonic adenocar-
cinoma to originate from a diverticular out pouching
present within the serosal fat. Detailed sectioning con-
firmed the connection to the overlying colonic mucosa
thus establishing the diverticular status of the bowel. The
free "isolated" cells supported the view that the adenocar-
cinoma had perforated through the diverticulum and was
present on the peritoneal surface. These "free tumor cells"
though admixed with the granulosa cell tumor cells still
respected their individual boundaries. Extensive co-exist-
ing diverticular disease of the sigmoid was also present.
The adenocarcinoma component was moderately well-
differentiated with the mucinous component represent-
ing less than 50% of the tumor and there was no evidence
of a pre-existing polyp at the site of the carcinoma. The
free serosal surface was involved by the ovarian granulosa
cell tumor. Sampling of the subserosal fat showed evi-
dence of irregular nodules keeping with venous invasion
of an extramural variety along with perineural invasion
both from the granulosa cell component. A small focus of
giant cell granulomatous response was also observed in
the serosal fat. The proximal and surgical margins of the
lesion were free of tumor and no separate polyps were
identified in the remainder of the bowel sampled. Twenty-
one lymph nodes had been harvested from the specimen,
of which, one was positive for the presence of metastatic
colonic adenocarcinoma.
Immunohistochemical studies clearly delineated the two
components of the collision tumor even in the closely
admixed zones on the serosal surface of the lesion. The
adenocarcinoma cells were strongly positive to low
molecular weight keratin, and CK20 (Figure 4A), while
CK7, vimentin, and S100 were negative. This immunohis-
tochemical profile of CK20 being positive and CK7 being
negative in the adenocarcinomatous component con-
firmed the histomorphological diagnosis of colonic aden-
ocarcinoma. P53 antibodies were markedly over
expressed in the majority of the adenocarcinoma cells.
CA125 remained negative in these cells. Meanwhile, the
granulosa cell tumor recurrence regions showed complete
negativity to keratin antibodies (low molecular weight
keratin, CK 7, CK 20), P53, and CA125. However, these
cells were strongly positive to vimentin and inhibin (Fig-
ure 4B) with focal positivity with S100 antibodies. This
immunohistochemical profile of CK7-, CK20-, inhibin+,
vimentin+ confirmed the histomorphological diagnosis
of granulosa cell tumor of the ovary. Table 1 summarizes
the dilution, clone and the type of the antibodies used in
this case.
A, B – Collision tumor with the two neoplastic components  seen with their individual staining pattern with cytokeratin 20  antibodies strongly positive in the adenocarcinomatous com- ponent (asterisk) in A and negative in the granulosa cell com- ponent (pound) Figure 4
A, B – Collision tumor with the two neoplastic components 
seen with their individual staining pattern with cytokeratin 20 
antibodies strongly positive in the adenocarcinomatous com-
ponent (asterisk) in A and negative in the granulosa cell com-
ponent (pound). While the vimentin antibodies are strongly 
positive in the granulosa cell component (asterisk) and nega-
tive in the adenocarcinomatous component (asterisk) in B. 
Inhibin staining pattern was identical to that seen with vimen-
tin antibodies.
A, B, C – Colonic adenocarcinoma colliding with granulosa  cell tumor (3A) showing many architectural patterns includ- ing diffuse (3A) (asterisk), microfollicular (3B) and cords of  cells (3C) Figure 3
A, B, C – Colonic adenocarcinoma colliding with granulosa 
cell tumor (3A) showing many architectural patterns includ-
ing diffuse (3A) (asterisk), microfollicular (3B) and cords of 
cells (3C).World Journal of Surgical Oncology 2007, 5:118 http://www.wjso.com/content/5/1/118
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Thus, the final completed pathological analysis of the
specimen revealed a primary colonic adenocarcinoma
arising in a large sigmoid diverticulum coexisting with
another tumor phenotype. The histomorphology and the
results of immunohistochemistry, together with the
retrieval of the sixteen year old records, confirmed the sec-
ond neoplasm to be a recurrent ovarian granulosa cell
tumor comprising 60% of the specimen. Though coexist-
ent with the primary adenocarcinoma cells, the two tumor
phenotypes respected each others boundaries with no dif-
fuse intermingling or transition between the two. At three
month postoperative follow-up she developed local recur-
rence of the granulosa cell tumor in the pelvis and lung
metastases within six months confirmed pathologically
by image guided fine needle aspiration biopsy. She
declined adjuvant chemotherapy and died within a year's
follow-up.
Discussion
Colonic adenocarcinoma is the most common malignant
neoplasm occurring in the colon. Collision tumors of the
colon on the other hand are extremely rare neoplasms.
The admixtures of such two independent tumor pheno-
types include the presence of adenocarcinomas with carci-
noid [3], transitional cell carcinoma [4], and lymphomas
[6-9]. The occurrence of both colonic adenocarcinoma
and granulosa cell tumor is uncommon, and to the best of
our knowledge has never been reported in the English lit-
erature. Although there is no satisfactory explanation for
the occurrence of such collision tumors, theories relating
to the occurrence of such collision tumors include:
1) Simultaneous proliferation of two different cell lines.
2) Common origin from pluripotent precursor stem cell
that differentiates into two components.
3) Chance apposition of two unrelated tumors.
Questions that are not easy to answer and which require
further exploration include
a) Are these tumors simple incidental associations?
b) Are these lesions connected by a causal relationship?
c) Does a single carcinogenic agent interact with two
neighboring tissues inducing development of tumors of
different histological types in the same organ?
Furthermore, in the diagnosis of collision tumors it is
important to exclude rare tumors resulting from one can-
cer metastasizing to one another. In our case, it is hypoth-
esized that some central carcinogenic stimulus induced
the development of the primary adenocarcinoma of the
colon – a change in the immunological surveillance status
– which "awakened" the sleeping dormant granulosa
tumor cells resulting in a sixteen year delayed recurrence.
Granulosa cell tumors are rarely aggressive, with a five
year survival reported to be as high as 86% [11]. The stage
of the disease is critical for prognosis, as stages 3 and 4
have a five year survival of only 33.3% [12]. Delayed
recurrences of granulosa cell tumors a well known,
though uncommon, has a median relapse time of 4–6
years [13] with the longest reported delayed recurrence
being 37 years after the initial diagnosis [14]. Further,
though colonic adenocarcinoma is a common neoplasm,
its origin within a sigmoid diverticulum is uncommon
and rare [15-17] adding further complexity to this case in
its overall clinical presentation and evolution.
Due to the infrequency of such lesions the biological
behavior of colliding tumors is difficult to ascertain in the
context of which component will determine the final out-
come in terms of disease free survival times. It is debatable
whether such outcomes are dependent on either the most
predominant component of the collision and/or the more
histologically aggressive component of the collision
tumor. Molecular genetic analysis may be of special
importance for the diagnosis of collision tumors consist-
ing of poorly differentiated neoplasm's such as T cell lym-
phomas and anaplastic carcinoma when
immunohistochemistry remains inconclusive. It is likely
such collision tumors are under diagnosed in the routine
laboratory.
Conclusion
Clinical awareness and recognition of such tumors are
important as they will dictate appropriate treatment strat-
egies dependent on the individual biological aggressive-
ness of each of the tumor components. Our report
highlights the need for histopathologists, surgeons, and
Table 1: Summarizes the different immunohistochemical 
antibodies used to confirm the two histological components of 
the collision tumor of the colon.
Ab/Enzymes Dilution Clone Poly/
Monoclonal
Animal
Ck-7 1:35 OVTL12-30 Monoclonal Mouse
Ck-20 1:25 KS20-8 Monoclonal Mouse
Low Molecular 
Weight Keratin
1:50 C51 Monoclonal Mouse
S100 1:4000 N/A Polyclonal Rabbit
Inhibin 1:5 R1 Monoclonal Mouse
Vimentin 1:4000 V9 Monoclonal Mouse
CA125 1:20 M111 Monoclonal Mouse
P53 1:150 DO-7 Monoclonal Mouse
Ck-7, Inhibin, S100, CA125, p53-DakoCytomation; Mississauga, ON
Vimentin, Low Molecular Weight Keratin-Intermedico; Markham, ON
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oncologists to be aware of the existence of such rare colli-
sions tumors. As seen in our case, the delayed recurrence
of granulosa cell tumor of the ovary sixteen years after the
initial presentation was the key determining factor in
tumor recurrence, tumor progression, and tumor metasta-
sis within three months, which ultimately lead to acceler-
ated death within a year of clinical presentation. In
conclusion, accurate identification and recognition of
both components of the collision neoplasm is important
in guiding decisions regarding overall prognosis, adjuvant
therapeutic options, and survival which may be depend-
ent on either of the components.
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